Testosterone Saliva ELISA
- Regulatory Status
- RUO
- Kit size
- 12 x 8
- Method
- ELISA
- Incubation time
- 1 x 2 h, 1 x 30 min
- Standard range
- 10 - 900 pg/mL
- Specimen / Volumes
- 50 µL saliva/without extraction
- Substrate / isotope
- TMB 450 nm
Improved Saliva Testing of hormone levels
Enzyme immunoassay for the quantitative determination of free testosterone in human saliva.
Benefits of the Testosterone Saliva ELISA
- Calibration to the LC-MS/MS
- Simplified pipetting protocol
- Alignment to entire Saliva line
Consistent and reliable processing within Saliva product line
Our Saliva ELISA product line (Cortisol, Testosterone, Progesterone, DHEA) can be processed in a similar way and be easily performed in combination:
- The TMB, washing and stop solutions are interchangeable;
- The enzyme conjugate, the substrate and stop solutions are uniformly pipetted with 100 µL;
- The kits contain as few as 6 standards and 2 controls;
- Only 50 µL sample volume are required;
- All kits use the same sample diluent buffer.
Automation
The IBL International Testosterone Saliva ELISA (RE52631) can be adapted on different ELISA processors. The combined use of assays, process script and automate has to be validated individually on site by each laboratory.
Measurement of Testosterone in saliva
Only 1-2% of the hormone Testosterone is unbound from plasma proteins and therefore biologically active. It is released via the salivary glands and mainly transformed to 5a-dihydrotestosterone. The concentration of testosterone in saliva, reflects however the level of free testosterone in plasma.
Pulsatile dynamics
Due to the pulsatile dynamics of Testosterone secretion repeated saliva sampling is recommended. We recommend collecting 3 to 5 saliva samples within 2 hours. In the laboratory, equal volumes of the individual saliva samples can be mixed. This mixed sample results in a mean free Testosterone value, which represents the active hormone concentration in a reproducible way.
Therefore measuring the free testosterone in saliva is a convenient non-invasive method. Easier sample collection without repeated venipunctures and reduced stress on the specimen offer benefits to the patient while sensibility and accuracy of the results are ensured.
For concrete data please consult the Instruction for Use in the download box on the top right side.
1. Tygi, V., Scordo, M., Yoon, R. S., Liporace, F. A., & Greene, L. W. (2017). Revisiting the role of testosterone: Are we missing something?. Reviews in urology, 19(1), 16.
2. Burger, H. G. (2002). Androgen production in women. Fertility and sterility, 77, 3-5.
3. Goncharov, N., Katsya, G., Dobracheva, A., Nizhnik, A., Kolesnikova, G., Herbst, V., & Westermann, J. (2006). Diagnostic significance of free salivary testosterone measurement using a direct luminescence immunoassay in healthy men and in patients with disorders of androgenic status. The Aging Male, 9(2), 111-122.
4. David Wild. The Immunoassay Handbook. Theory and Applications of Ligand Binding, ELISA and Related Techniques. 4th Edition. 2013, pp 722, 731-733, 746, 748-749.
5. Shea, J. L., Wong, P. Y., & Chen, Y. (2014). Free testosterone: clinical utility and important analytical aspects of measurement. Advances in clinical chemistry, 63, 59-84.
6. Lewis, J.G. Steroid Analysis in Saliva: An overview. Clin Biochem Rev 2006, Volume 27:139-146
7. Goncharov N, Katsya G, Dobracheva A, Nizhnik A, Kolesnikova G, Herbst V, Westermann J. 2006. Diagnostic significance of free salivary testosterone measurement using a direct luminescence immunoassay in healthy men and in patients with disorders of androgenic status. Aging Male. 9(2): 111-22.
8. Brambilla, D. J., Matsumoto, A. M., Araujo, A. B., & McKinlay, J. B. (2009). The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men. The Journal of Clinical Endocrinology & Metabolism, 94(3), 907-913.
9. Wood, P. (2009). Salivary steroid assays–research or routine?. Annals of clinical biochemistry, 46(3), 183-196.
10. Škrgatić, L., & Trgovčić, I. (2013). Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome. Acta dermatovenerologica Croatica: ADC, 21(2), 105-112.
11. Lothar Thomas. Labor und Diagnose. Indikation und Bewertung von Laborbefunden für die medizinische Diagnostik. Band 2. 2012 Chapter 34, pp. 1841-1842.
Our Product Families
Our comprehensive immunoassay portfolio includes a number of specialty diagnostic immunoassays for endocrinology, immunology and autoimmunity, as well as for diagnosis of multiple infectious diseases. We are pioneers and market leaders in saliva diagnostics, with over 40 years of experience supplying a broad portfolio of luminescence- and ELISA-based tests, including our highly acclaimed HMGB1 and MuSK-Ab ELISAs.
And as experts in laboratory automation, we can support our customers with the protocols for open ELISA platforms.
All products are only available for sale to laboratory professionals and may not be available in all countries. Availability and regulatory status may vary across regions depending on local country-specific registration. Please always read and follow the instructions for use.
All of our assays have been designed and manufactured to meet the highest global regulatory requirements and quality standards. Tecan is certified under ISO 9001:2015, ISO 13485:2016 and is audited by a notified body according to Medical Device Single Audit Program (MDSAP).
This is who we are.
As part of the Tecan Group, we have a leading market position in diagnostics and research, with over 40 years of experience in the development, manufacture and supply of enzyme-, radiolabel- and luminescence-based immunoassays.
Our range of high-quality immunoassays is supported by a diverse portfolio of automated solutions, making us the perfect partner for you and your customers.
Happy to help.
At Tecan, we are driven to improve people’s lives and health.